VC
KNSA icon

Vivo Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Vivo Capital’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,151,622
Closed -$17.6M – 64
2020
Q3 		$17.6M Hold
1,151,622
– – 1.02% 27
2020
Q2 		$29.3M Buy
1,151,622
+392,572
+52% +$8.2M 2.1% 11
2020
Q1 		$11.8M Buy
+759,050
New +$11.9M 1.06% 27
2019
Q3 		– Sell
-843,478
Closed -$11.4M – 21
2019
Q2 		$11.4M Hold
843,478
– – 1.07% 26
2019
Q1 		$15.2M Buy
843,478
+578,600
+218% +$11.2M 1.52% 17
2018
Q4 		$7.44M Hold
264,878
– – 0.95% 28
2018
Q3 		$6.75M Buy
264,878
+78,805
+42% +$1.53M 0.68% 30
2018
Q2 		$3.23M Buy
+186,073
New +$3.37M 0.42% 33

Other funds holding KNSA

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.6B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return